Xue‐cheng Bi

824 total citations
30 papers, 667 citations indexed

About

Xue‐cheng Bi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xue‐cheng Bi has authored 30 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xue‐cheng Bi's work include Signaling Pathways in Disease (8 papers), Peptidase Inhibition and Analysis (7 papers) and Pediatric Urology and Nephrology Studies (4 papers). Xue‐cheng Bi is often cited by papers focused on Signaling Pathways in Disease (8 papers), Peptidase Inhibition and Analysis (7 papers) and Pediatric Urology and Nephrology Studies (4 papers). Xue‐cheng Bi collaborates with scholars based in China, United States and Hong Kong. Xue‐cheng Bi's co-authors include Weide Zhong, Zhaodong Han, Qi-Shan Dai, Huichan He, Yongkang Ye, Guohua Zeng, Yuxiang Liang, Gang Zhu, Weijun Qin and Zhi‐Nan Chen and has published in prestigious journals such as International Journal of Cancer, BioMed Research International and Endocrine Related Cancer.

In The Last Decade

Xue‐cheng Bi

28 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue‐cheng Bi China 15 383 216 165 160 102 30 667
Yuting Yi China 14 252 0.7× 155 0.7× 114 0.7× 192 1.2× 52 0.5× 54 631
Suk‐young Lee South Korea 16 395 1.0× 216 1.0× 111 0.7× 148 0.9× 60 0.6× 43 719
Kan Wu China 15 341 0.9× 221 1.0× 211 1.3× 229 1.4× 67 0.7× 77 776
Xinrui Tian China 8 383 1.0× 117 0.5× 104 0.6× 115 0.7× 92 0.9× 13 746
Nayara Izabel Viana Brazil 16 420 1.1× 142 0.7× 175 1.1× 394 2.5× 63 0.6× 64 752
Leonardo Vincenti Italy 12 284 0.7× 175 0.8× 252 1.5× 156 1.0× 26 0.3× 37 660
Juan José Mora Román Costa Rica 13 230 0.6× 199 0.9× 140 0.8× 83 0.5× 72 0.7× 32 716
Jianhua Zhou China 14 332 0.9× 67 0.3× 71 0.4× 101 0.6× 77 0.8× 60 610
Youichi Mizutani Japan 18 410 1.1× 295 1.4× 72 0.4× 126 0.8× 209 2.0× 41 803

Countries citing papers authored by Xue‐cheng Bi

Since Specialization
Citations

This map shows the geographic impact of Xue‐cheng Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐cheng Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐cheng Bi more than expected).

Fields of papers citing papers by Xue‐cheng Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐cheng Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐cheng Bi. The network helps show where Xue‐cheng Bi may publish in the future.

Co-authorship network of co-authors of Xue‐cheng Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐cheng Bi. A scholar is included among the top collaborators of Xue‐cheng Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐cheng Bi. Xue‐cheng Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Yi‐Hao, Jia-Hong Chen, Xiaohui Ling, et al.. (2024). Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma. Endocrine Related Cancer. 31(3). 1 indexed citations
3.
Pu, Xiao‐Yong, et al.. (2021). Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy. BMC Geriatrics. 21(1). 49–49. 7 indexed citations
4.
5.
Bi, Xue‐cheng, Jiumin Liu, & Xiao‐Yong Pu. (2017). The comparative study of retroperitoneal laparoscopic pyelolithotomy and percutaneous nephrolithotomy in treating renal pelvic stone. Zhonghua miniao waike zazhi. 38(2). 92–94.
6.
Huang, Yaqiang, Zhaodong Han, Yuxiang Liang, et al.. (2013). Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer. Medical Oncology. 31(1). 820–820. 43 indexed citations
7.
Han, Zhaodong, Yanqiong Zhang, Huichan He, et al.. (2012). Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis. Medical Oncology. 29(4). 2877–2888. 40 indexed citations
8.
Bi, Xue‐cheng, Jiumin Liu, Huichan He, et al.. (2012). Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas. Clinical & Translational Oncology. 14(3). 190–196. 18 indexed citations
9.
Zhong, Weide, Yuxiang Liang, Sharron X. Lin, et al.. (2011). Expression of CD147 is associated with prostate cancer progression. International Journal of Cancer. 130(2). 300–308. 43 indexed citations
10.
Zhong, Weide, Yongkang Ye, Zhaodong Han, et al.. (2010). Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer. Cancer Epidemiology. 34(4). 478–482. 12 indexed citations
11.
Ye, Yongkang, Xue‐cheng Bi, Huichan He, et al.. (2010). CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma. Clinical and Experimental Medicine. 10(3). 153–158. 17 indexed citations
12.
Hu, Zhiquan, Zhaohui Zhong, Liping Xie, et al.. (2009). Fluid intake and the risk of bladder cancer: Results from the South and East China case‐control study on bladder cancer. International Journal of Cancer. 127(3). 638–645. 33 indexed citations
13.
Liang, Yuxiang, Huichan He, Zhaodong Han, et al.. (2009). CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value. Cancer Investigation. 27(7). 788–793. 48 indexed citations
14.
Bi, Xue‐cheng, Binghua Zhang, Yongkang Ye, et al.. (2009). Pathogen Incidence and Antibiotic Resistance Patterns of Catheter-Associated Urinary Tract Infection in Children. Journal of Chemotherapy. 21(6). 661–665. 11 indexed citations
15.
Bi, Xue‐cheng, et al.. (2009). Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Medical Oncology. 27(1). 145–151. 22 indexed citations
16.
Zhu, Gang, Huichan He, Xue‐cheng Bi, et al.. (2009). Inhibition of Proliferation, Invasion, and Migration of Prostate Cancer Cells by Downregulating Elongation Factor-1α Expression. Molecular Medicine. 15(11-12). 363–370. 15 indexed citations
17.
Han, Zhaodong, Xue‐cheng Bi, Weijun Qin, et al.. (2008). CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer. Pathology & Oncology Research. 15(3). 369–374. 38 indexed citations
18.
Zhong, Weide, Jinyu Peng, Dinglan Wu, et al.. (2008). Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clinical and investigative medicine. 31(1). E8–E15. 87 indexed citations
19.
He, Huichan, Xue‐cheng Bi, Zhiwei Zheng, et al.. (2008). Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer. Medical Oncology. 26(3). 303–308. 18 indexed citations
20.
Zhong, Weide, et al.. (2006). cDNA macroarray for analysis of gene expression profiles in prostate cancer. Chinese Medical Journal. 119(7). 570–573. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuting Yi Breakdown of academic impact, for papers by Suk‐young Lee Breakdown of academic impact, for papers by Kan Wu Breakdown of academic impact, for papers by Xinrui Tian Breakdown of academic impact, for papers by Nayara Izabel Viana Breakdown of academic impact, for papers by Leonardo Vincenti Breakdown of academic impact, for papers by Juan José Mora Román Breakdown of academic impact, for papers by Jianhua Zhou Breakdown of academic impact, for papers by Youichi Mizutani
Rankless by CCL
2026